首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >Posttransplant lymphoproliferative disorders: A continued threat for kidney transplant recipients
【24h】

Posttransplant lymphoproliferative disorders: A continued threat for kidney transplant recipients

机译:移植后淋巴细胞增生性疾病:肾脏移植受者的持续威胁

获取原文
获取原文并翻译 | 示例
           

摘要

Lymphoid neoplasia continues to pose a serious problem for immunosuppressed recipients of solid organ transplants. Previous studies, derived mostly from analyses of registry data, suggest that posttransplant lymphoma occurs in l%-2% of kidney transplant recipients, translating to a risk that is 10- to 20-fold higher than that in the general population. Over 90% of cases of posttransplant lymphoma have been linked to proliferation of Epstein-Barr virus (EBV)-infected B cells resulting from suppression of normal immune surveillance by immunosuppressive therapy.
机译:对于实体器官移植的免疫抑制接受者,淋巴样赘生物继续构成严重问题。先前的研究主要来自对注册表数据的分析,这些研究表明,移植后淋巴瘤发生在1%-2%的肾脏移植接受者中,其风险比一般人群高10至20倍。超过90%的移植后淋巴瘤病例与通过免疫抑制疗法抑制正常免疫监视而导致的受爱泼斯坦-巴尔病毒(EBV)感染的B细胞增殖有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号